Table of Contents
Chapter 1. Laying the Groundwork (General Background, Glycemia, Lipids, Renal Evaluation, Hypertension, Aspirin, Smoking Cessation, Rationale for Algorithms); Chapter 2. Evidence-Based Principles of Dietary Therapy; Chapter 3. Glycemia (Goals of Therapy, Principles of Treatment, Non-Insulin Drugs, Metformin, Sulfonylurea Agents and Glinides, Thiazolidinediones; Incretins – Background, Incretin Analogs (Exenatide), Dipeptidyl Peptidase Inhibitors (Sitagliptin), Alpha-Glucosidase Inhibitors, Markedly Symptomatic Type 2 Diabetic Patients. Pramlintide, Self Monitoring of Blood Glucose, Insulin, General Approach, Bedtime Insulin / Daytime Oral Antidiabetes Drugs, Multiple Injections, Premixed Insulins, Delayed Response to NPH Insulin, Correction Doses, Glycemia Algorithm)Chapter 4. Dyslipidemia (Goals of Therapy, Principles of Treatment, Adverse Events, Medications, Dyslipidemia Algorithm); Chapter 5. Hypertension, Background (Aldosterone Receptor Antagonists, Alpha-Adrenergic Receptor Atagonists, Alpha-Adrenergic Receptor Agonists, Angiotensin Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, Beta-Adrenergic Receptor, Antagonists, Calcium Channel Antagonists, Renin Inhibitors, Thiazide and Loop Diuretics, Vasodilators (Direct), Hypertension Algorithm)
About the Author
Mayer Davidson, MD is a well-known and respected researcher and an expert in clinical endocrinology. He is a Professor of Medicine at the UCLA School of Medicine and a Principal Investigator at the Clinical Center for Research Excellence at the Charles Drew University of Medicine and Science (Los Angeles). He is very active in the ADA community and was Editor-in-Chief of Diabetes Care from 2002 to 2006 and President of the American Diabetes Association from 1997 to 1998.
